RxDoctor Payments Data

Judd Allen, MD

Orthopaedic Surgery · Saratoga Springs, UTNPI 1639463714

Payments from drug & device makers

$14,128in general payments, 2019–2025

Across 48 payments — averaging $294.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vericel Corporation$8K
  • Smith+Nephew$5K
  • Active Medical, LLC$844
  • Stryker$65
  • Dynasplint Systems Inc.$34
  • Zimmer Biomet$25
  • plus $55 from 3 others

What the payments were for

  • Speaking & faculty fees$10,38073%
  • Travel & lodging$1,41710%
  • Food & beverage$1,48711%
  • Education$8446%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vericel Corporation27$7,661
Smith+Nephew14$5,443
Active Medical, LLC1$844
Stryker1$65
Dynasplint Systems Inc.1$34
Zimmer Biomet1$25
Pacira Pharmaceuticals Incorporated1$25
Johnson & Johnson1$15
Bioventus LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,128 in reported general payments places this provider in the 70th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$12,942
Medicare patients
37
Services billed
196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib15$265

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Saratoga Springs

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →